Menu Search
Equities

Koninklijke Philips NV

PHG:NYQ

Koninklijke Philips NV

Actions
Health CareHealth Care Equipment & Services
  • Price (USD)54.40
  • Today's Change0.000 / 0.00%
  • Shares traded532.74k
  • 1 Year change+30.26%
  • Beta0.8890
Data delayed at least 15 minutes, as of Feb 27 2021 00:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Jan-20
  • 15-Oct-20
  • 19-Nov-20
  • 17-Dec-20
  • 25-Feb-21
Select bar for recommendation details.
Recommendations25-Feb-21
Buy2
Outperform0
Hold0
Underperform0
Sell0

Share price forecast

The 2 analysts offering 12 month price targets for Koninklijke Philips NV (ADR) have a median target of 57.00, with a high estimate of 59.00 and a low estimate of 55.00. The median estimate represents a 4.78% increase from the last price of 54.40.
High8.5%59.00
Med4.8%57.00
Low1.1%55.00

Dividends

Historical dividend information is not available for Koninklijke Philips NV.
Div growth (TTM)-100.00%
More ▼

Earnings history & estimates

Koninklijke Philips NV (ADR) reported annual 2020 earnings of 2.26 per share on Jan 25, 2021.
Average growth rate-2.08%
More ▼

Revenue history & estimates

Koninklijke Philips NV (ADR) had revenues for the full year 2020 of 22.27bn. This was 2.16% above the prior year's results.
Average growth rate+0.30%
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.